Early Phase Development

Latest News

Credit: RAJCREATIONZS | stock.adobe.com
Phase I Trial Supports Development of Once-Yearly Lenacapavir as Long-Acting HIV PrEP Option

March 13th 2025

Phase I trial results show the potential of once-yearly lenacapavir as a long-acting PrEP option for HIV, supporting further clinical development in a more diverse population.

Credit: JYPIX | stock.adobe.com
Decentralized Phase I Trial Highlights Promise of Remote Data Collection to Improve Clinical Research

January 22nd 2025

Four-Steps to Accelerate Study Start-up Cycles
Four-Steps to Accelerate Study Start-up Cycles

March 5th 2024

How AI is Changing Early Drug Development
How AI is Changing Early Drug Development

February 22nd 2024

Scientists analyzing the vital substance of the blood vessels in a lab, Medical scientist for treatment concept. | Image Credit: © Puwasit Inyavileart - stock.adobe.com
NEXT Oncology Joins Proxima Clinical Research Early Phase Oncology Network

July 14th 2023

Video Interviews

More News

© 2025 MJH Life Sciences

All rights reserved.